Anti-Ricin [A9]
AB03296-1.159
ApplicationsELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityPlant
TargetLOC8261245
Overview
- SupplierAbsolute Antibody
- Product NameAnti-Ricin [A9]
- Delivery Days Customer9
- Application Supplier NoteThe VHH antibody was specific for RTA as confirmed by competition ELISA. The crystal structure of ricin catalytic subunit in complex with the VHH antibody was determined. The antibody had relatively weak toxin-neutralizing activity (IC50 ~750 nM), as shown by Vero cell cytotoxicity assays. The antibody binding affinity (KD) for ricin holotoxin (0.08 nM). The binding affinity, and, toxin-neutralizing activity of the antibody was mediated by CDR2 containing five consecutive Gly residues that interact with alpha-helix B. In order to prove this, a variant of the antibody lacking Gly AC151residue 59 (A9delta59) was generated. Binding studies and toxinneutralizing assays confirmed that the removal of a single glycine residue from A9s CDR2 significantly reduced binding affinity for RTA (~10-fold weaker; 1.76 nM versus 0.102 nM) and eliminated toxin-neutralizing activity (Rudolph et al., 2018; PMID: 30265352).
- ApplicationsELISA, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDA9
- Gene ID8261245
- Target nameLOC8261245
- Target descriptionricin
- Target synonymsRCOM_2159810, rRNA N-glycosylase, ricin, proricin A chain, ricin E beta chain, ricin homolog, truncated
- HostMouse
- IsotypeIgG1
- Protein IDP02879
- Protein NameRicin
- ReactivityPlant
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116161
